Home > Press > Starpharma and Durex Sign Co-Development Agreement for VivaGel-Coated Condoms
Starpharma Holdings Ltd today announced the signing of an agreement with SSL International plc , owner of Durex(R), the world's leading condom brand.
Starpharma and Durex Sign Co-Development Agreement for VivaGel-Coated Condoms
SYDNEY, Australia | Posted on October 16th, 2007
The agreement, under which a commercial licence will be negotiated, sets out a co-development program for condoms with a VivaGel(R) coating. Undisclosed fees are payable to Starpharma under the co-development agreement, which also provides for the commencement of regulatory and market development activities by the two parties.
SSL is the world's largest manufacturer of condoms with approximately 30% share of the global market for branded condom sales, selling into over 100 countries around the world. Global condom retail sales in 2005 were approximately $3.2 billion(1)(1), with the top four companies representing as much as 70% of the market.
"We are delighted to be working with SSL, whom we believe will be an excellent co-development partner for VivaGel(R) as a condom coating," said Starpharma's Chief Executive Officer, Dr. Jackie Fairley. "In addition to SSL's unparalleled global commercial position and the strength of the Durex(R) brand, Starpharma also values the organisation's innovative approach, and its social-marketing program.
"Our development and commercialisation activities for VivaGel(R) are gathering momentum with this SSL agreement being the second of two unrelated condom coating agreements signed by Starpharma in the last three months," concluded Dr. Fairley.
VivaGel(R) has been shown to have potent contraceptive and microbicidal properties in animal studies, and is also under development as a stand-alone gel to prevent the transmission of STIs, including HIV and genital herpes.
(1)(1) "Condoms: A Global Strategic Business Report", March 2005, Global Industry Analysts Inc.
About Starpharma Holdings Limited
Starpharma Holdings Limited is a world leader in the development of dendrimer nanotechnology for pharmaceutical, life-science and other applications. SPL is principally composed of two operating companies, Starpharma Pty Ltd in Melbourne, Australia and Dendritic Nanotechnologies, Inc. in Michigan, USA. Products based on SPL's dendrimer technology are already on the market in the form of diagnostic elements and laboratory reagents.
The Company's lead pharmaceutical development product is VivaGel(R) (SPL7013 Gel), a vaginal microbicide designed to prevent the transmission of STIs, including HIV and genital herpes.
For more information, please click here
Tel: +61 2 9237 2800
Mob: +61 417 382 391
Dr. Jackie Fairley
Chief Executive Officer
+61 3 8532 2704
+61 3 8532 2702
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Nanovations Sets new Benchmark in Automotive Windscreen Coating Durability: Nanovations new automotive glass coating Vision Protect, sets new benchmark in glass coating durability March 23rd, 2014
Tawada CleanTech to show fabric duct and eco cool coating in MegaBuild March 21st, 2014
NEI Introduces Self-healing Anti-corrosion Coating for Zinc-Plated and Galvanized Steel March 14th, 2014
Cima NanoTech Announces Commercial Production of its SANTE(R) FS200 Touch Films for Large Format Touch Screens February 19th, 2014
Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014
PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014
Global leader in solar cell manufacturing eyes New York for major expansion outside of Japan: CNSE and Solar Frontier Explore $700 Million Investment, Job Creation in New York State April 22nd, 2014
ASM International Repositions Brand and Introduces New Logo; Looks to Future of Materials Science Innovation: New logo celebrates organizationís history and provides fresh elements for future growth April 21st, 2014
Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014
Peer Reviewed and Approved for Science by the the Washington Academy of Sciences April 3rd, 2014
University of Waterloo Visits China to Strengthen Bonds With Research Partners April 21st, 2014
Novel stapled peptide nanoparticle combination prevents RSV infection, study finds April 17th, 2014
Scientists Capture Ultrafast Snapshots of Light-Driven Superconductivity: X-rays reveal how rapidly vanishing 'charge stripes' may be behind laser-induced high-temperature superconductivity April 16th, 2014
Scalable CVD process for making 2-D molybdenum diselenide: Rice, NTU scientists unveil CVD production for coveted 2-D semiconductor April 8th, 2014